Tañola, Baby Girl .

HRN: 28-53-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/14/2026
02/20/2026
IVT
51mg
Q24
PSNB (PROM X 12 Hours)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: